BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15705277)

  • 41. Mezlocillin in the treatment of gonorrhoea.
    Lassus A; Renkonen OV
    Br J Vener Dis; 1979 Jun; 55(3):191-3. PubMed ID: 111766
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison between bacampicillin and amoxycillin in treating genital and extragenital infection with Neisseria gonorrhoeae and pharyngeal infection with Neisseria meningitidis.
    Edwards LD; Gartner T
    Br J Vener Dis; 1984 Dec; 60(6):380-3. PubMed ID: 6440658
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010.
    Ison CA; Hussey J; Sankar KN; Evans J; Alexander S
    Euro Surveill; 2011 Apr; 16(14):. PubMed ID: 21492528
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Suboptimal therapy and clinical management of gonorrhoea in an area with high-level antimicrobial resistance.
    Chen PL; Hsieh YH; Lee HC; Ko NY; Lee NY; Wu CJ; Chang CM; Lee CC; Ko WC
    Int J STD AIDS; 2009 Apr; 20(4):225-8. PubMed ID: 19304963
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neisseria gonorrhoeae isolates from four centres in Papua New Guinea remain susceptible to amoxycillin-clavulanate therapy.
    Toliman PJ; Lupiwa T; Law GJ; Reeder JC; Siba PM
    P N G Med J; 2010; 53(1-2):15-20. PubMed ID: 22768475
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of azithromycin 1 g single dose in the management of uncomplicated gonorrhoea.
    Waters LJ; Boag FC; Betournay R
    Int J STD AIDS; 2005 Jan; 16(1):84. PubMed ID: 15705283
    [No Abstract]   [Full Text] [Related]  

  • 47. No way back for quinolones in the treatment of gonorrhoea.
    Goold PC; Bignell CJ
    Sex Transm Infect; 2006 Jun; 82(3):225-6. PubMed ID: 16731673
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neisseria gonorrhoeae and fosfomycin: Past, present and future.
    Tesh LD; Shaeer KM; Cho JC; Estrada SJ; Huang V; Bland CM; DiMondi VP; Potter AN; Hussein G; Bookstaver PB
    Int J Antimicrob Agents; 2015 Sep; 46(3):290-6. PubMed ID: 26145201
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Emergence of ciprofloxacin resistant Neisseria gonorrhoeae in north India.
    Sethi S; Sharma D; Mehta SD; Singh B; Smriti M; Kumar B; Sharma M
    Indian J Med Res; 2006 May; 123(5):707-10. PubMed ID: 16873916
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The National Gonorrhea Therapy Monitoring Study: I. Review of treatment results and of in-vitro antibiotic susceptibility, 1972-1978.
    Guinan ME; Biddle J; Thornsberry C; Reynolds G; Zaidi A; Wiesner P
    Sex Transm Dis; 1979; 6(2 Suppl):93-102. PubMed ID: 158836
    [No Abstract]   [Full Text] [Related]  

  • 51. Treating genitourinary and pharyngeal gonorrhoea with single dose ceftriaxone.
    Christophersen J; Bollerup AC; From E; Rønne-Rasmussen JO; Quitzau K
    Genitourin Med; 1989 Jan; 65(1):14-7. PubMed ID: 2921047
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The treatment of pharyngeal gonorrhoea with a single oral dose of cefixime.
    McMillan A; Young H
    Int J STD AIDS; 2007 Apr; 18(4):253-4. PubMed ID: 17509176
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of azithromycin 1g single dose in the management of uncomplicated gonorrhoea.
    Habib AR; Fernando R
    Int J STD AIDS; 2004 Apr; 15(4):240-2. PubMed ID: 15075017
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The prevalence and antibiotics susceptibility pattern of Neisseria gonorrhoeae in patients attending OPD clinics at St. Mary's Hospital Lacor Uganda.
    Amito Florence P; Otim F; Okongo F; Ogwang M; Greco D
    J Prev Med Hyg; 2012 Dec; 53(4):186-9. PubMed ID: 23469585
    [TBL] [Abstract][Full Text] [Related]  

  • 55. First Neisseria gonorrhoeae strain with resistance to cefixime causing gonorrhoea treatment failure in Austria, 2011.
    Unemo M; Golparian D; Stary A; Eigentler A
    Euro Surveill; 2011 Oct; 16(43):. PubMed ID: 22085601
    [TBL] [Abstract][Full Text] [Related]  

  • 56. RE: Ciprofloxacin resistance in Great Yarmouth and Waveney district.
    Harry TC
    J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):216-7. PubMed ID: 16441638
    [No Abstract]   [Full Text] [Related]  

  • 57. A review of augmentin treatment regimes in gonorrhoea due to penicillinase-producing Neisseria gonorrhoeae: 1981-1987.
    Robinson OP
    J Chemother; 1989 Jul; 1(4 Suppl):890-2. PubMed ID: 16312690
    [No Abstract]   [Full Text] [Related]  

  • 58. Gonorrhoea: test of cure for sensitive bacteria? Use of genotyping to disprove treatment failure.
    Komolafe AJ; Sugunendran H; Corkill JE
    Int J STD AIDS; 2004 Mar; 15(3):212. PubMed ID: 15038877
    [No Abstract]   [Full Text] [Related]  

  • 59. Ampicillin therapy for pharyngeal gonorrhea.
    Di Caprio JM; Reynolds J; Frank G; Carbone J; Nishimura R
    JAMA; 1978 Apr; 239(16):1631-3. PubMed ID: 416234
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antibiotic-resistant gonorrhoea in a London GUM clinic.
    Nwokolo NC; Boag FC
    Int J STD AIDS; 2002 Feb; 13(2):137-8. PubMed ID: 11839173
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.